Featured Image

WASHINGTON, D.C. (LifeSiteNews) – The U.S. Department of Health and Human Services (HHS) recently announced it placed a $290 million order for drugs made to help people in “nuclear emergencies.”

“As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc,” HHS announced on October 4.

The drug “is approved to treat blood cell injuries that accompany acute radiation syndrome [ARS] in adult and pediatric patients,” HHS announced.

“ARS, also known as radiation sickness, occurs when a person’s entire body is exposed to a high dose of penetrating radiation, reaching internal organs in a matter of seconds,” health officials explained. “Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding.”

News of the announcement comes at the same time Russian and Ukrainian leaders have both spoken publicly about the possibility of nuclear strikes.

Ukrainian President Volodomyr Zelenskyy called for “preventative strikes” to stop Russia from using nuclear missiles, but later his media team said he meant sanctions.

Russian President Vladimir Putin “ initially suggested using nuclear weapons in Ukraine, as he said on Sept. 21 that Russia would ‘use everything it can’ when ‘its territorial integrity is threatened,’” Fox News reported.

The U.S. would likely be involved in any nuclear military action.

“U.S. officials have asserted that Washington would take decisive action if Russia moves to use nuclear weapons and warned of heavy consequences for Putin,” The Hill reported. President Joe Biden said at a Thursday fundraiser that the risk of a nuclear “Armageddon” is at the highest level in 60 years.